• Something wrong with this record ?

Current patterns of care and outcomes for dermatofibrosarcoma protuberans: An international multi-institutional collaborative

LK. Winer, R. Akumuo, JD. Fredette, M. Deng, JS. Hasler, SH. Greco, M. von Mehren, AJ. Bartholomew, DG. Blazer, L. Gabrielova, D. Adamkova, E. Bernard-Bedard, C. Nessim, A. Kollár, R. Olariu, R. Cencelj-Arnez, D. Hompes, SJ. Ford, K. Cardona, K....

. 2025 ; 131 (1) : e35468. [pub] 20240710

Language English Country United States

Document type Journal Article, Multicenter Study

Persistent link   https://www.medvik.cz/link/bmc25010531

Grant support
P30CA006927 NIH HHS - United States
P30CA006927 NIH HHS - United States

BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is a cutaneous sarcoma with an infiltrative growth pattern that makes it challenging to clear margins. High quality data regarding DFSP natural history, management, and outcomes are limited. METHODS: Data were retrospectively collected for adult DFSP patients who underwent resection at 10 institutions in eight countries. Demographics, tumor characteristics, treatment strategies, and outcomes were analyzed. RESULTS: Analysis included 347 patients consisting of young (median, 42 years), White (76.2%), males (54.2%) with truncal lesions (57.3%). The majority (76.8%) were symptomatic at presentation. Preoperative imaging was used in 55.9% of cases. Diagnosis was established with excisional biopsy in 50.9% versus incisional biopsy in 25.0% of cases. Despite planned margins of >1.0 cm in 67.4% of cases, only 69.0% of patients achieved R0 resection. Twenty-two percent of patients underwent at least one re-excision. R0 resection was achieved at a second procedure in 80.2% and a third procedure in 86.2%. Ultimately, R0 resection was feasible in 89.5% of all patients. Fibrosarcomatous transformation (FST) was observed in 12.6%. In total, 6.6% (N = 23) recurred (17 local, six distant). Of the six distant recurrences, 50.0% had FST. With a median follow-up of 47.0 months, disease-specific survival rate was 98.8%. In multivariable analysis, R0 margins at index resection were associated with wider circumferential margins and non-FST histology. CONCLUSIONS: In this international, multicenter collaborative, DFSP practice patterns were heterogeneous but achieved favorable recurrence rates and survival. Multiple excisions to clear margins remain commonplace and can inform future efforts to optimize margin selection.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010531
003      
CZ-PrNML
005      
20250429134527.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cncr.35468 $2 doi
035    __
$a (PubMed)38985726
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Winer, Leah K $u Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA $1 https://orcid.org/0000000278998873
245    10
$a Current patterns of care and outcomes for dermatofibrosarcoma protuberans: An international multi-institutional collaborative / $c LK. Winer, R. Akumuo, JD. Fredette, M. Deng, JS. Hasler, SH. Greco, M. von Mehren, AJ. Bartholomew, DG. Blazer, L. Gabrielova, D. Adamkova, E. Bernard-Bedard, C. Nessim, A. Kollár, R. Olariu, R. Cencelj-Arnez, D. Hompes, SJ. Ford, K. Cardona, K. Sato, S. Iwata, JM. Farma, AM. Villano
520    9_
$a BACKGROUND: Dermatofibrosarcoma protuberans (DFSP) is a cutaneous sarcoma with an infiltrative growth pattern that makes it challenging to clear margins. High quality data regarding DFSP natural history, management, and outcomes are limited. METHODS: Data were retrospectively collected for adult DFSP patients who underwent resection at 10 institutions in eight countries. Demographics, tumor characteristics, treatment strategies, and outcomes were analyzed. RESULTS: Analysis included 347 patients consisting of young (median, 42 years), White (76.2%), males (54.2%) with truncal lesions (57.3%). The majority (76.8%) were symptomatic at presentation. Preoperative imaging was used in 55.9% of cases. Diagnosis was established with excisional biopsy in 50.9% versus incisional biopsy in 25.0% of cases. Despite planned margins of >1.0 cm in 67.4% of cases, only 69.0% of patients achieved R0 resection. Twenty-two percent of patients underwent at least one re-excision. R0 resection was achieved at a second procedure in 80.2% and a third procedure in 86.2%. Ultimately, R0 resection was feasible in 89.5% of all patients. Fibrosarcomatous transformation (FST) was observed in 12.6%. In total, 6.6% (N = 23) recurred (17 local, six distant). Of the six distant recurrences, 50.0% had FST. With a median follow-up of 47.0 months, disease-specific survival rate was 98.8%. In multivariable analysis, R0 margins at index resection were associated with wider circumferential margins and non-FST histology. CONCLUSIONS: In this international, multicenter collaborative, DFSP practice patterns were heterogeneous but achieved favorable recurrence rates and survival. Multiple excisions to clear margins remain commonplace and can inform future efforts to optimize margin selection.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mladý dospělý $7 D055815
650    12
$a dermatofibrosarkom $x patologie $x chirurgie $x terapie $x mortalita $7 D018223
650    _2
$a resekční okraje $7 D000072662
650    _2
$a lokální recidiva nádoru $x patologie $7 D009364
650    _2
$a retrospektivní studie $7 D012189
650    12
$a nádory kůže $x patologie $x chirurgie $x mortalita $x terapie $7 D012878
650    _2
$a výsledek terapie $7 D016896
650    12
$a internacionalita $7 D038622
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Akumuo, Rita $u Department of General Surgery, Temple University Hospital, Philadelphia, Pennsylvania, USA
700    1_
$a Fredette, Jordan D $u Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
700    1_
$a Deng, Mengying $u Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
700    1_
$a Hasler, Jill S $u Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
700    1_
$a Greco, Stephanie H $u Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
700    1_
$a von Mehren, Margaret $u Division of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA $1 https://orcid.org/000000016158890X
700    1_
$a Bartholomew, Alex J $u Department of Surgery, Duke University Hospital, Durham, North Carolina, USA
700    1_
$a Blazer, Dan G $u Department of Surgery, Duke University Hospital, Durham, North Carolina, USA
700    1_
$a Gabrielova, Lucie $u Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic
700    1_
$a Adamkova, Dagmar $u Department of Surgery, Masaryk Memorial Cancer Institute, Brno, Zluty kopec, Czech Republic
700    1_
$a Bernard-Bedard, Ericka $u Division of Surgical Oncology, Ottawa Hospital, Ottawa, Ontario, Canada
700    1_
$a Nessim, Carolyn $u Division of Surgical Oncology, Ottawa Hospital, Ottawa, Ontario, Canada
700    1_
$a Kollár, Attila $u Department of Medical Oncology, Inselspital, Bern University Hospital, Univesity of Bern, Bern, Switzerland
700    1_
$a Olariu, Radu $u Department of Plastic and Hand Surgery, Inselspital, Bern University Hospital, Freiburgstrasse, Switzerland
700    1_
$a Cencelj-Arnez, Romi $u Division of Surgery, Institute of Oncology Ljubljana, Ljubljana, Slovenia
700    1_
$a Hompes, Daphne $u Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium
700    1_
$a Ford, Samuel J $u Sarcoma Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom
700    1_
$a Cardona, Kenneth $u Division of Surgical Oncology, Emory University Hospital, Atlanta, Georgia, USA
700    1_
$a Sato, Kenji $u Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan
700    1_
$a Iwata, Shintaro $u Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan $1 https://orcid.org/000000022024514X
700    1_
$a Farma, Jeffrey M $u Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
700    1_
$a Villano, Anthony M $u Division of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
773    0_
$w MED00001031 $t Cancer $x 1097-0142 $g Roč. 131, č. 1 (2025), s. e35468
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38985726 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134522 $b ABA008
999    __
$a ok $b bmc $g 2311728 $s 1247612
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 131 $c 1 $d e35468 $e 20240710 $i 1097-0142 $m Cancer $n Cancer $x MED00001031
GRA    __
$a P30CA006927 $p NIH HHS $2 United States
GRA    __
$a P30CA006927 $p NIH HHS $2 United States
LZP    __
$a Pubmed-20250415
Back

Find record

Citation metrics

Archiving options